{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:50:23Z","timestamp":1794639023032,"version":"4.9.1"},"reference-count":46,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2004,11,1]]},"DOI":"10.1080\/10428190412331283279","type":"journal-article","created":{"date-parts":[[2004,7,30]],"date-time":"2004-07-30T08:30:03Z","timestamp":1091176203000},"page":"2281-2289","source":"Crossref","is-referenced-by-count":27,"title":["C-kit Receptor (CD117) Expression on Plasma Cells in Monoclonal Gammopathies"],"prefix":"10.1080","volume":"45","author":[{"given":"Maria","family":"Kraj","sequence":"first","affiliation":[{"name":"Department of Hematology Institute of Hematology and Blood Transfusion Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard","family":"Pog\u0142\u00f3d","sequence":"additional","affiliation":[{"name":"Department of Hematology Institute of Hematology and Blood Transfusion Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kope\u0107-szl\u0119zak","sequence":"additional","affiliation":[{"name":"Department of Physiopathology Institute of Hematology and Blood Transfusion Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula","family":"Soko\u0142owska","sequence":"additional","affiliation":[{"name":"Department of Hematology Institute of Hematology and Blood Transfusion Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Wo\u017aniak","sequence":"additional","affiliation":[{"name":"Department of Physiopathology Institute of Hematology and Blood Transfusion Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kruk","sequence":"additional","affiliation":[{"name":"Department of Hematology Institute of Hematology and Blood Transfusion Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,7,1]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-2725(99)00078-3"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1159\/000046556"},{"key":"CIT0003","first-page":"78, 30 \u2014 37","author":"Ashman L.K.","year":"1991","journal-title":"Blood"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1084\/jem.174.1.63"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.3109\/10428199909083383"},{"key":"CIT0006","first-page":"127, 1596 \u2014 159","author":"Bayer-Garner I.B.","year":"2003","journal-title":"Archives of Pathology and Laboratory Medicine"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.3.785.785"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(200004)63:4<226::AID-AJH11>3.0.CO;2-5"},{"key":"CIT0009","first-page":"176","volume":"4","author":"Di Paola R.S.","year":"1997","journal-title":"\"Evidence for a functional c-kit receptor in melanoma, breast cancer and lung carcinoma cells\" Cancer Gene Therapy"},{"key":"CIT0010","first-page":"3319","author":"Krystal G.W.","year":"2000","journal-title":"Clinical Cancer Research"},{"key":"CIT0011","first-page":"35, 884 \u2014 890","author":"Naraghi S.","year":"2000","journal-title":"Journal of Pediatric Surgery"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203698"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01449.x"},{"key":"CIT0014","first-page":"760","volume":"88","author":"Lemoli R.M.","year":"1994","journal-title":"\"Expression and functional role of c-kit ligand (SCF) in human multiple myeloma cells\", British Journal of Haematology"},{"key":"CIT0015","first-page":"457","volume":"20","author":"Lemoli R.M.","year":"1996","journal-title":"\"C-kit ligand (SCF) in human multiple myeloma cells\", Leukemia and Lymphoma"},{"key":"CIT0016","first-page":"669","volume":"106","author":"Gooding R.P.","year":"1999","journal-title":"\"Phenotypic and molecular analysis of six human cell lines derived from patients with plasma cell dyscrasia\", British Journal of Haematology"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.3109\/10428199809057558"},{"key":"CIT0018","first-page":"5019","author":"Lin B.","year":"2003","journal-title":"Cancer Research"},{"key":"CIT0019","first-page":"123","volume":"73","author":"Pogl\u00f3d R.","year":"2001","journal-title":"Immunology Letters"},{"key":"CIT0020","first-page":"493\u2014 502","volume":"1","author":"Capdeville R.","year":"2002","journal-title":"Drug Discovery"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.6.1928"},{"key":"CIT0022","first-page":"344, 1052\u2014 1056","author":"Joensuu H.","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"CIT0023","unstructured":"Dispenzieri, A., Witzig, T.E., Lacy, M.Q., Rajkumar, S.V., Geyer, S.M., Kimlinger, T., et al. (2002) \"A phase II trial of Gleevec TM in patients with refractory\/relapsed myeloma\", Blood, 100(11), 814a, abstract # 3217."},{"key":"CIT0024","unstructured":"Kraj, M., Pogl\u00f3d, R., Kopee-Szlgzak, J., Sokolowska, U., Kruk, B. and Woniak, J. (2002) \"Expression of the CD117 antigen (c-kit) on plasma cells in monoclonal gammopathies.\", 1. International Journal of Hematology, 76\\(suppl. 1), 24. 2. The Hematology Journal, 2003; 4\\(suppl. 1), S113."},{"key":"CIT0025","unstructured":"Kraj, M., Pogl\u00f3d, R., Kope\u00e9-Szlgak, J., Sokolowska, U., Wo\u00b1niak, J. and Kruk, B. (2002) \"Expression of the CD117 antigen (c-kit) on myelomatous plasma cells and its clinical implications. 1\", Blood, 100(11Pt2), 367b. 2. The Hematology Journal, 4\\(suppl. 2), 153. 3. Immunology Letters, 2003; 87(1\u20133), 209."},{"key":"CIT0026","first-page":"842","volume":"36","author":"Dune B.G.M.","year":"1975","journal-title":"correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival\", Cancer"},{"key":"CIT0027","first-page":"443","volume":"12","author":"Miwa H.","year":"1998","journal-title":"AML of monocyte origin and hematopoietic precursor cell origin\", Leukemia"},{"key":"CIT0028","unstructured":"Davis, K.A., Abrams, B., Hoffman, R.A. and Bishop, J.E. (1996) \"Quantitation and valence of antibodies bound to cells\", Cytome-try, AC150\\(suppl 8), 150."},{"key":"CIT0029","first-page":"83, 392\u2014 397","author":"Cascavilla N.","year":"1998","journal-title":"Haematologica"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.10068"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(01)00182-5"},{"key":"CIT0032","first-page":"117, 301 \u2014 305","author":"Hans C.P.","year":"2002","journal-title":"American Journal of Clinical Pathology"},{"key":"CIT0033","first-page":"1211\u2013122!","volume":"11","author":"Khalidi H.S.","year":"1998","journal-title":"Modern Pathology"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1996.tb08993.x"},{"key":"CIT0035","first-page":"121 \u2014 131","volume":"107","author":"Almeida J.","year":"1999","journal-title":"\"High sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma\", British Journal of Haematology"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-003-0934-8"},{"key":"CIT0037","first-page":"1692\u2014 1703","volume":"20","author":"Heinrich MC.","year":"2002","journal-title":"a novel molecular approach to the treatment of KIT-positive malignancies\", Journal of Clincal Oncology"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.3.925"},{"key":"CIT0039","first-page":"170\u2014 177","volume":"16","author":"Inokouchi K.","year":"2002","journal-title":"\"Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia-potential clinical significance\", Leukemia"},{"key":"CIT0040","first-page":"99, 10700 \u2014 107","author":"Roumiantsev S.","year":"2002","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"CIT0041","first-page":"3068","volume":"21","author":"Pierce A.","year":"2002","journal-title":"\"BCR-ABL alters the proliferation and differentiation response of multipotent hematopoietic cells to stem cell factor\", Oncogene"},{"key":"CIT0042","first-page":"139","author":"Buchdunger E.","year":"2000","journal-title":"Journal of Pharmacology and Experimental Therapy"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1126\/science.289.5486.1938"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04706.x"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.1.3"},{"issue":"1","key":"CIT0046","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2012-04-425231","volume":"88","author":"San Miguel J.F.","year":"1997","journal-title":"Blood"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428190412331283279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:10:28Z","timestamp":1692112228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428190412331283279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,1]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11,1]]}},"alternative-id":["10.1080\/10428190412331283279"],"URL":"https:\/\/doi.org\/10.1080\/10428190412331283279","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,1]]}}}